- Home
- BLTE vs LTH Comparison
BLTE vs LTH Comparison
Compare BLTE & LTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLTE | LTH |
|---|---|---|
| Founded | 2018 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 6.2B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BLTE | LTH |
|---|---|---|
| Price | $137.18 | $32.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $198.00 | $40.57 |
| AVG Volume (30 Days) | 104.2K | ★ 3.6M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 124.32 |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | ★ $2,995,255,000.00 |
| Revenue This Year | N/A | $11.98 |
| Revenue Next Year | $492.11 | $11.45 |
| P/E Ratio | ★ N/A | $82.06 |
| Revenue Growth | N/A | ★ 14.28 |
| 52 Week Low | $56.68 | $24.14 |
| 52 Week High | $200.00 | $35.33 |
Technical Indicators
Market Signals| Indicator | BLTE | LTH |
|---|---|---|
| Relative Strength Index (RSI) | 31.51 | 57.12 |
| Support Level | $103.94 | $25.23 |
| Resistance Level | $172.02 | $35.33 |
| Average True Range (ATR) | 7.11 | 1.63 |
| MACD | -1.16 | -0.02 |
| Stochastic Oscillator | 7.06 | 60.61 |
Price Performance
Historical ComparisonAbout BLTE Belite Bio Inc
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
About LTH Life Time Group Holdings Inc.
Life Time Group Holdings Inc is a lifestyle and leisure brand offering health, fitness, and wellness experiences to a community. It is engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation, and spa centers in a resort-like environment, principally in residential locations of metropolitan areas in the United States and Canada.